Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2015

Open Access 01-12-2015 | Case report

Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report

Authors: Bilal Gani Taib, Andrew J Kinshuck, Philip Milburn-McNulty, Lauren Fratalia, Leigh Forsyth, David Husband, Terry M Jones, Anu Jacob

Published in: Journal of Medical Case Reports | Issue 1/2015

Login to get access

Abstract

Introduction

Opsoclonus-myoclonus syndrome is a rare autoimmune syndrome usually seen in children and very rarely in adults. It typically presents with a triad of opsoclonus, myoclonus and ataxia, and is most often associated with a tumor or after an infection or vaccination. Around half of all adult cases are paraneoplastic in origin, and isolated case reports include associations with lung, breast and ovarian cancers. To the best of our knowledge, this is the first-ever reported case of paraneoplastic opsoclonus-myoclonus syndrome occurring in association with a nasopharyngeal carcinoma.

Case presentation

A 50-year-old British Caucasian woman presented with left-sided otalgia and subjective hearing loss. Over the coming weeks she developed subacute confusion and dizziness, leading to recurrent falls. Her clinical examination revealed opsoclonus, myoclonus and signs of cerebellar dysfunction. Subsequent magnetic resonance imaging revealed a left-sided nasopharyngeal carcinoma, which was confirmed on biopsy. A tapering dose of steroids and a five-day course of intravenous immunoglobulins, followed by a combination of chemo-radiotherapy for the nasopharyngeal carcinoma, led to a significant clinical improvement. At six months follow-up she had no signs of focal neurological deficit, apart from the inability to tandem walk. We believe that the typical clinical features, presence of a tumor and response to treatment support a paraneoplastic aetiology.

Conclusions

We show that a nasopharyngeal carcinoma can be associated with adult onset opsoclonus-myoclonus syndrome. Both neurologists and otorhinolaryngologists must be aware of such a presentation. Prognosis of the syndrome depends on early and adequate management of the tumor, therefore prompt identification of the syndrome and the underlying tumor is essential.
Literature
3.
go back to reference Gorman MP. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome. Curr Opin Pediatr. 2010;22(6):745–50.CrossRefPubMed Gorman MP. Update on diagnosis, treatment, and prognosis in opsoclonus-myoclonus-ataxia syndrome. Curr Opin Pediatr. 2010;22(6):745–50.CrossRefPubMed
4.
go back to reference Desai J, Mitchell WG. Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome. J Child Neurol. 2012;27(11):1482–8.CrossRefPubMed Desai J, Mitchell WG. Acute cerebellar ataxia, acute cerebellitis, and opsoclonus-myoclonus syndrome. J Child Neurol. 2012;27(11):1482–8.CrossRefPubMed
5.
go back to reference Digre KB. Opsoclonus in adults - report of 3 cases and review of the literature. Arch Neurol. 1986;43(11):1165–75.CrossRefPubMed Digre KB. Opsoclonus in adults - report of 3 cases and review of the literature. Arch Neurol. 1986;43(11):1165–75.CrossRefPubMed
6.
7.
go back to reference Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135–40.CrossRefPubMedPubMedCentral Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75(8):1135–40.CrossRefPubMedPubMedCentral
8.
go back to reference Suchowersky O, Comella C. Hyperkinetic movement disorders. 1st ed. New York, USA: Humana Press; 2012. p. 350.CrossRef Suchowersky O, Comella C. Hyperkinetic movement disorders. 1st ed. New York, USA: Humana Press; 2012. p. 350.CrossRef
9.
go back to reference Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Verhulst SJ. CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Mov Disord. 2004;19(7):770–7.CrossRefPubMed Pranzatelli MR, Travelstead AL, Tate ED, Allison TJ, Verhulst SJ. CSF B-cell expansion in opsoclonus-myoclonus syndrome: a biomarker of disease activity. Mov Disord. 2004;19(7):770–7.CrossRefPubMed
11.
go back to reference Tresca P, Faure Conter C, Coze C, Haouy S, Diop M, Fasola S, et al. Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg). Institut Curie, France. Trial Identifier:NCT01868269. Clinical Trials.gov. Opsoclonus USA: National Library of Medicine 2014 [updated May 2014; cited 2014 17/05/2014]. Available from: https://clinicaltrials.gov/ct2/show/NCT01868269?term=opsoclonus&rank=3. Tresca P, Faure Conter C, Coze C, Haouy S, Diop M, Fasola S, et al. Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg) Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg). Institut Curie, France. Trial Identifier:NCT01868269. Clinical Trials.gov. Opsoclonus USA: National Library of Medicine 2014 [updated May 2014; cited 2014 17/05/2014]. Available from: https://​clinicaltrials.​gov/​ct2/​show/​NCT01868269?​term=​opsoclonus&​rank=​3.
Metadata
Title
Opsoclonus-myoclonus syndrome associated with a nasopharyngeal tumor in an adult: a case report
Authors
Bilal Gani Taib
Andrew J Kinshuck
Philip Milburn-McNulty
Lauren Fratalia
Leigh Forsyth
David Husband
Terry M Jones
Anu Jacob
Publication date
01-12-2015
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2015
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-015-0605-9

Other articles of this Issue 1/2015

Journal of Medical Case Reports 1/2015 Go to the issue